Croatia
Tuberculosis profile
Population  2012 4.3 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.061 (0.06–0.062) 1.4 (1.4–1.4)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0 (0–0)
Prevalence  (includes HIV+TB) 0.84 (0.34–1.6) 20 (7.9–36)
Incidence  (includes HIV+TB) 0.62 (0.54–0.7) 14 (13–16)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.03 (0.02–0.03)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 140 (26) Relapse 0 (0)
Smear-negative 90 (17) Treatment after failure 0 (0)
Smear-unknown / not done 246 (46) Treatment after default 0 (0)
Extrapulmonary 63 (12) Other 36 (100)
Other 0 (0)      
Total new 539   Total retreatment 36  
           
Other (history unknown) 0        
Total new and relapse 539   Total cases notified 575  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 2.7 1.4 1.3
Age < 15 0 10 2
Laboratories 2012
Smear (per 100 000 population)  
Culture (per 5 million population)  
Drug susceptibility testing (per 5 million population)  
Is second-line drug susceptibility testing available?  
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive     Is rifampicin used
throughout treatment for
new patients?
 
New smear-negative/extrapulmonary    
Retreatment    
TB/HIV 2012 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 0.28 (0.01–1.6) 2.5 (0.06–13)
MDR-TB cases among notified pulmonary
TB cases
1 (0–8) 1 (0–5)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 271 (100%) 28 (78%) 299
Laboratory-confirmed MDR-TB cases 1 0 1
Patients started on MDR-TB treatment      
Financing TB control 2013
National TB programme budget (US$ millions)  
% Funded domestically  
% Funded internationally  
% Unfunded  
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-20 Data: www.who.int/tb/data